Palliative sedation is the use of medications to lower a dying person’s awareness in order to relieve suffering that cannot be controlled any other way. It is reserved for people with a terminal illness whose symptoms have failed to respond to standard treatments. The European Association for Palliative Care defines it as “the monitored use of medications intended to induce a state of decreased or absent awareness (unconsciousness) in order to relieve the burden of otherwise intractable suffering.” It is not the same as euthanasia, and research suggests it does not shorten life when used appropriately.
When Palliative Sedation Is Considered
Palliative sedation is only an option when a symptom is classified as “refractory,” meaning it has not responded to multiple conventional treatments and other options are either unlikely to work within a reasonable time frame or would cause intolerable side effects. There is no universal checklist for what counts as refractory. Clinical teams make that judgment based on the individual patient’s situation, but several general criteria apply: the person must have a terminal illness where death is expected, standard therapies must have failed at their maximum doses, and the only remaining path to relief involves reducing consciousness.
The three most common reasons for palliative sedation are delirium (36.1% of cases), pain (31.9%), and difficulty breathing (25%). Sometimes the trigger is not that a treatment has completely failed but that higher doses of a conventional medication would create dangerous side effects. For example, repeated high doses of anti-nausea drugs can cause heart rhythm problems, making a sedating alternative safer. In other situations, a patient may be acutely agitated and delirious, and waiting for slower-acting approaches would leave them suffering or put caregivers at risk.
Types: Intermittent vs. Continuous
Palliative sedation is not always deep or permanent. It can be given in two broad forms: intermittent (short-term) sedation and continuous sedation until death.
Intermittent sedation is used when symptoms flare at specific times, such as overnight agitation. The person is sedated for a period, then allowed to wake. This approach preserves windows of awareness where they can interact with family or reassess their goals of care.
Continuous sedation ranges from light to deep. In lighter forms, the goal is to keep the person settled and just rousable, similar to a light sleep. Clinicians in the UK often aim for this “settled but rousable” state, treating the sedation almost as a side effect of managing difficult physical symptoms rather than as the primary goal. In deeper forms, the person is brought to full unconsciousness and kept there until death. This deeper approach is typically reserved for the most extreme cases where lighter sedation cannot control suffering. In Belgium, for instance, clinicians more commonly establish deep sedation quickly, either by starting low and increasing rapidly or by beginning with high doses.
How Sedation Is Monitored
Clinical teams use standardized scales to track how deeply a person is sedated. The most widely recommended tool is the Richmond Agitation-Sedation Scale, or RASS, which scores a patient from +4 (combative and agitated) to -5 (completely unarousable). It requires no input from the patient. A nurse or doctor simply observes the person’s response to voice and gentle physical stimulation. A version adapted specifically for palliative care settings has shown strong reliability between different observers, meaning two clinicians assessing the same patient will generally agree on the score. Regular reassessment ensures the sedation stays at the level needed to control symptoms without going deeper than necessary.
Does It Shorten Life?
This is the question families ask most often, and the evidence is reassuring. A systematic review covering 11 studies and 2,325 patients found that palliative sedation did not appear to shorten survival when used appropriately. Patients who received sedation survived a median of 7 to 36.6 days, while non-sedated patients survived 4 to 39.5 days. Those differences were not statistically significant. One study actually found that sedated patients lived slightly longer. The studies involved people with terminal cancer, so the findings may not generalize to every illness, but the overall pattern is consistent: properly administered palliative sedation relieves suffering without hastening death.
How It Differs From Euthanasia
Palliative sedation and euthanasia are fundamentally different in intent, method, and outcome. The ethical distinction rests on a principle called the doctrine of double effect: an action that produces a good effect (relieving suffering) can be justified even if it carries a foreseeable but unintended bad effect (potentially hastening death). For palliative sedation to meet this standard, the clinician must intend only the relief of suffering. Death is neither the goal nor the means of achieving comfort. The medications reduce awareness; they do not end life.
In euthanasia or physician-assisted death, causing death is explicitly intended and is the mechanism through which suffering ends. That disqualifies it from double-effect reasoning entirely. Palliative sedation uses sedating medications at doses calibrated to consciousness, not to vital functions. The person dies of their underlying illness, not from the sedation itself.
What Happens With Food and Fluids
Once a person is deeply sedated, they can no longer eat or drink on their own, which raises difficult questions for families. The clinical consensus is that artificial nutrition and hydration near the end of life is unlikely to prolong life and can increase suffering. Potential complications include infection, aspiration, diarrhea, skin breakdown, and fluid overload. Confused or agitated patients receiving tube feeding may need physical restraints to prevent them from pulling out the tube, adding to their distress.
Thirst, a common worry for families, can often be managed with simple mouth care or ice chips rather than intravenous fluids. The decision to provide, continue, or stop artificial nutrition is made by weighing its benefits and burdens in the context of the person’s goals. Some families and clinical teams opt for a time-limited trial with clear, measurable endpoints to determine whether artificial hydration is helping. If it is not achieving its purpose, it can be withdrawn like any other medical intervention.
What Families Should Expect
Watching a loved one be sedated can be profoundly difficult, even when everyone agrees it is the right choice. Research into family experiences highlights several things that make the process more bearable. Families consistently value open, honest information delivered in clear language. They want healthcare professionals to acknowledge who their loved one is as a person, not just a patient with a set of symptoms. They also want to feel recognized in their own role as caregivers and to know that the goals and preferences they discussed with one clinician will be understood by the entire care team.
Practically, families should expect the clinical team to explain what the sedation will look like: the person will appear to be sleeping, their breathing pattern may change as their illness progresses, and they will likely not respond to voice or touch depending on the depth of sedation. The team will continue to monitor comfort and adjust medications as needed. Families can still sit with their loved one, talk to them, hold their hand. The person’s hearing may persist even when they cannot respond, and many palliative care teams encourage families to speak as though their loved one can hear them.
Guidelines and Safeguards
Multiple national and international organizations have published clinical guidelines for palliative sedation. The American Academy of Hospice and Palliative Medicine issued a position statement in 2014, and the National Hospice and Palliative Care Organization published one in 2010. More recent guidelines have come from France’s National Authority for Health (2020), Japan’s Society for Palliative Medicine (2020), and both the German Society for Palliative Medicine and the Government of Western Australia (2021). While these guidelines differ in specifics, they share common principles: palliative sedation should be a last resort after conventional treatments have failed, the patient (or their surrogate decision-maker) must give informed consent, the depth of sedation should be the minimum necessary to relieve suffering, and the process should be regularly reassessed and documented.